Summary
Doxycycline and minocycline are second-generation tetracyclines. They are readily absorbed, distributed throughout the organism as a function of their lipophilicity and eliminated in both the urine and the faeces. The influence of age, renal disease, malnutrition and hyperlipidaemia is reviewed, together with the main pharmacokinetic interactions.
Similar content being viewed by others
References
Alestig K. Studies on absorption and excretion of doxycycline with reference to renal function. Opuscula Medica, Royal College of Physiology, London S 33: 45–50, 1974
Althuisius HF, Jauw TH, Janbroers JM. Ein doxycycline derivaat met bijzonndere eigenschappen: doxycycline natrium metafosfaat complex. Acta Therapeutica 9: 275–287, 1983
Barling RWA, Selkon JB. The penetration of antibiotics into cerebrospinal fluid and brain tissue. Journal of Antimicrobial Chemotherapy 4: 203–227, 1978
Benassayag E, Bergogne-Berezin E, Berthelot C. Etude de la diffusion de la minocycline dans le tissu prostatique. Annales d’Urologie 13: 179–181, 1979
Bergogne-Berezin E, Berthelot G, Benassayag E. Etude de la diffusion de la minocycline dans le tissu prostatique. Médecine et Maladies Infectieuses 8: 102–105, 1978
Bergogne-Berezin E, Berthelot G, Kafe H, Lambert-Zechovsky N, Morel C, Benard Y. Etude de la pénétration des tétracyclines dans les sécrétations bronchiques. Médecine et Maladies Infectieuses 9: 688–692, 1979
Bergogne-Berezin E, Lambert-Zechovsky N. La doxycycline; quelques propriétés bactériologiques et pharmacologiques. Gazette Médicale de France 83: 53–58, 1976
Bessard G, Mouries D, Seynave B, Phelip X. Diffusion hémosynoviale de la doxycycline chez les malades ayant un épanchement articulaire. Nouvelle Presse Médicale 9: 84–85, 1980
Bistue C, Perez P, Becquart D, Vincon G, Albin H. Effet du dimeticone sur la biodisponibilité de la doxycycline. Thérapie 42: 13–16, 1987
Blanchard P, Rudhardt M, Fabre J. Behaviour of doxycycline in the tissues. Chemotherapy 21: 8–18, 1975
Blanchard P, Rudhardt M, Fabre J, Leski M. Pharmacocinétique de divers antibiotiques dans les tissus. Schweizerische Medizinische Wochenschrift 107: 589–597, 1977
Böcker R, Muhlberg W, Platt D, Estler CJ. Serum level, half-life and apparent volume of distribution of doxycycline in geriatric patients. European Journal of Clinical Pharmacology 30: 105–108, 1986
Bordes R, Leluc R, Le Bourgeois M, Cudennec Y, Risgallah A. Etude du taux de doxycycline dans l’amydale palatine, dans la muqueuse du sinus maxillaire et dans les sécrétations sinusiennes. Nouvelle Presse Médicale 9: 131–134, 1980
Brihmer C, Brundin J. Levels of ampicillin and doxycycline in human oviduct mucosa and serum. Acta Obstetricia et Gynecologica Scandinavica 62: 231–234, 1983
Brihmer C, Brundin J. Doxycycline in human oviduct mucosa and plasma 24–30 hours after an oral dose of 100mg. Acta Obstetricia et Gynecologica Scandinavica 64: 529–530, 1985
Brogan TD, Lynne Neale, Ryley HC, Davies BH, Charles J. The secretion of minocycline in sputum during therapy of bronchopulmonary infection in chronic chest diseases. Journal of Antimicrobial Chemotherapy 3: 247–251, 1977
Campistron G, Coulais Y, Caillard C, Mosser J, Pontagnier H, et al. Pharmacokinetics and bioavailability of doxycycline in humans. Arzneimittel-Forschung 36: 1705–1707, 1986
Carney S, Butcher RA, Dawborn JK, Pattison G. Minocycline excretion and distribution in relation to renal function in man. Clinical and Experimental Pharmacology and Physiology 1: 299–308, 1974
Clauzel AM, Bonnet D, Allegrini J, Simeon de Buochberg M. Concentrations de minocycline dans les sécrétations bronchiques. Nouvelle Presse Médicale 7: 4236, 1978
Clauzel AM, Simeon de Buochberg M, Michel FB. Pharmacocinétique comparative de differents antibiotiques dans les sécrétations bronchiques. Gazette Médicale de France 37–44, 1983
Curtis JR, Koutsaimanis KG, Buggey D, Eastwood JB. Evaluation of doxycycline administration in patients with renal failure and in normal subjects. Opuscula Medica, Royal College of Physiology, London S33: 51–56, 1974
Devulder B, Lemaire P, Tacquet A. Pharmacocinétique de la minocycline au cours de l’insuffisance rénale chronique. Gazette Médicale de France: 103–111, 1974
Dimmling Th, Vanderbeke O. Pharmacokinetik oral und intravenos verabreichbarer Tetracyclinpraparate. Medizinische Klinik 70: 279–285, 1975
Editorial. Les cyclines: grandeur, décadence et renouveau. Lettre Médicale d’Information 10: 37–40, 1981
Fabre J. Pharmacocinétique tissulaire de la doxycycline comparée à celle d’autres antibiotiques chez le rat. Nouvelle Presse Médicale 9: 71–76, 1980
Fourtillan JB. Pharmacocinétique de la minocycline chez l’homme. Gazette Médicale de France 45–52, 1983
Fourtillan JB, Lefebvre MA. Corrélations structure — activité dans la famille des tétracyclines. Nouvelle Presse Médicale 9(2): 64–70, 1980
Fourtillan JB, Lefebvre MA, Saux MC, Becq-Giraudon B. Etude pharmacocinétique de la doxycycline chez l’homme par Chromatographie liquide haute performance (administration de doses uniques de 200mg par voie intra-veineuse et par voie orale). Nouvelle Presse Médicale 9(2): 77–81, 1980
Fourtillan JB, Saux MC. Comportement pharmacocinétique des tétracyclines. Revue Association pour le Développement de la Pharmacie Hospitalière du Sud-Ouest 2: 23–39, 1977
Fourtillan JB, Saux MC. Intérêt des tétracyclines de deuxième génération. Comportement pharmacocinétique. Semaine des Hôpitaux Paris 54: 224–230, 1978
Fusgen I, Summa JD, Weih H. Verhalten der Serumspeigel von Oxytetracyclin und Doxycyclin unter der forcierten Diurese bei schweren Schlafmittelvergiftungen. Medizinische Klinik 72: 1645–1648, 1977
Garraffo R, Dellamonica P, Fournier JP, Lapalus Ph, Bernard E, et al. Effet de la rifampicine sur la pharmacocinétique de la doxycycline. Pathologie Biologie 35: 746–749, 1987
Hampel Von B, Lode H, Fenner H, Gikalov I. Doxycyclin-pellets: ein wirkstoffgerechte darreichungsform mit gesicherter bioaquivalenz. Arzneimittel-Forschung 30: 1938–1943, 1980
Heaney D, Eknoyan G. Minocycline and doxycycline kinetics in chronic renal failure. Clinical Pharmacology and Therapeutics 24: 233–239, 1978
Hensle TW, Prout Jr GR, Griffin P. Minocycline diffusion into benign prostatic hyperplasia. Journal of Urology 118: 609–611, 1977
Houin G, Brunner F, Nebout Th, Cherfaoui M, Lagrue G, et al. The effects of chronic renal insufficiency on the pharmacokinetics of doxycycline in man. British Journal of Clinical Pharmacology 16: 245–252, 1983
Jonas M, Cunha BA. Minocycline. Therapeutic Drug Monitoring 4: 137–145, 1982
Jonkman JHG, Van Der Boon WJV, Schoenmaker R, Holtkamp A, Hempenius J. No influence of doxycycline on theophylline pharmacokinetics. Therapeutic Drug Monitoring 7: 92–94, 1985
Korkeila J. Doxycyclin and oxytetracycline — effect on nitrogen balance during parenteral nutrition. Opuscula Medica, Royal College of Physiology, London S33: 38–44, 1974
Le Verge R, Javaudin L, Guesnier LR, Trebaul L. Etude pharmacocinétique de la minocycline après perfusion veineuse chez l’homme. Thérapie 31: 105–119, 1976
MacCulloch D, Richardson RA, Allwood GK. The penetration of doxycycline, oxytetracycline and minocycline into sputum. New Zealand Medical Journal 80: 300–302, 1974
Macdonald H, Kelly RG, Allen ES, Noble JF, Kanegis LA. Pharmacokinetic studies on minocycline in man. Clinical Pharmacology and Therapeutics 14: 852–861, 1973
Malmborg AS. Bioavailability of doxycycline monohydrate: a comparison with equivalent doses of doxycycline hydrochloride. Chemotherapy 30: 76–80, 1984
Marlin GE, Cheng S. Pharmacokinetics and tolerability of a single oral 600mg dose of doxycycline. Medical Journal of Australia 1: 575–576, 1979
Marlin GE, Cheng S, Thompson PJ. Sputum and plasma doxycycline concentrations after a single oral 600mg doxycycline dose in patients with chronic bronchitis. European Journal of Respiratory Disease 62: 276–280, 1981
Mattila MJ, Laisi U, Linnoila M, Salonen R. Effect of alcoholic beverages on the pharmacokinetics of doxycycline in man. Acta Pharmacologica et Toxicologica 50: 370–373, 1982
Michel G, Mosser J, Olle J. Pharmacokinetics and tissue localization of doxycycline polyphosphate and doxycycline hydrochloride in the rat. European Journal of Drug Metabolism and Pharmacokinetics 9: 149–153, 1984
Mingat J, Micoud M. Passage de la doxycycline à travers la barrière hémoméningée. Nouvelle Presse Médicale 9: 136–137, 1980
Nelis HJCF, De Leenheer AP. Metabolism of minocycline in humans. Drug Metabolism and Disposition 10: 142–146, 1982
Neuvonen PJ. Interactions with the absorption of tetracyclines. Drugs 11: 45–54, 1976
Poirier RH, Ellison AC. Ocular penetration of orally administered minocycline. Annals of Ophthalmology 1859–1861, 1979
Raghuran TC, Krishnaswamy K. Pharmacokinetics and plasma steady state levels of doxycycline in undernutrition. British Journal of Clinical Pharmacology 14: 785–789, 1982
Rogers JH, Barnwell PA, Waterman NG, Austin FD, Raff MJ. Clinical evaluation of intravenous minocycline. International Journal of Clinical Pharmacology 15: 194–198, 1977
Saux MC, Mosser J, Pontagnier H, Leng B. Pharmacokinetics of doxycycline polyphosphate (PPD), hydrochloride (CHD) and base (DB). European Journal of Drug Metabolism and Pharmacokinetics 6: 3–10, 1981
Saux MC, Mosser J, Pontagnier H, Leng B. Influence de l’absorption du lait sur la pharmacocinétique du polyphosphate de doxycycline. Vie Médicale 1129–1130, 1982a
Saux MC, Mosser J, Pontagnier H, Leng B. Pharmacokinetics of doxycycline polyphosphate after oral multiple dosing in humans. European Journal of Drug Metabolism and Pharmacokinetics 7: 123–130, 1982b
Saux MC, Mosser J, Pontagnier H, Leng B. Pharmacokinetic study of doxycycline polyphosphate after simultaneous ingestion of milk. European Journal of Drug Metabolism and Pharmacokinetics 8(1): 43–49, 1983
Schach Von Wittenau M. Pharmacokinetics of doxycycline. Opuscula Medica, Royal College of Physiology, London S33: 5–10, 1974
Schreiner A, Digranes A. Pharmacokinetics of lymecycline and doxycycline in serum and suction blister fluid. Chemotherapy 31: 261–265, 1985
Sklenar P, Spring P, Dettli L. One dose and multiple-dose kinetics of minocycline in patients with renal disease. Agents and Actions 7(3): 369–377, 1977
Sluczanowski W. Farmakokinetyka doksycykliny u chroych z przewlekla niewydolnoscia nerek leczonych hemodializa. Annales Academiae Medicae Stetinensis 27: 313–330, 1981
Smith C, Woods CG, Wood MJ. Absorption of minocycline. Journal of Antimicrobial Chemotherapy 13: 93, 1984
Squinazi F, Marsac A. Concentrations intra-sinusiennes de trois antibiotiques (amoxicilline, erythromycine, minocycyline). Comptes Rendus de Thérapeutique et de Pharmacologie Clinique 34: 1–4, 1985
Stenbaek O, Mybre E, Berdal BP. The effect of doxycycline on inulin and PAH clearance in advanced renal insufficiency. Opuscula Medica, Royal College of Physiology, London S33: 57–63, 1974
Sundberg L, Eden T, Ernstson S. Penetration of doxycycline in respiratory mucosa. Acta Oto-Laryngologica 96: 501–508, 1983
Vasuki K, Vimlesh S, Ghai OP. Serum minocycline kinetics in children. Indian Journal of Medicine Research 71: 764–767, 1980
Venho VMK, Salonen RO, Mattila MJ. Modification of the pharmacokinetics of doxycycline in man by ferrous sulphate or charcoal. European Journal of Clinical Pharmacology 14: 277–280, 1978
Veneg-Pedersen P, Miller R. Pharmacokinetics of doxycycline reabsorption. Journal of Pharmacological Sciences 69(2): 204–207, 1980
Welling PG, Koch PA, Lau CC, Craig WA. Bioavailability of tetracyclines and doxycycline in fasted and nonfasted subjects. Antimicrobial Agents and Chemotherapy 11(3): 462–469, 1977
Wetterfors J, Sjodahl R. Doxycycline concentrations in certain tissues following intravenous and oral administration. Opuscula Medica, Royal College of Physiology, London S33: 64–67, 1974
Whelton A. Utilisation des tétracyclines au cours de l’insuffisance rénale. Nouvelle Presse Médicale 9: 86–92, 1980
Whelton A, Blanco LJ, Carter GG, Craig TJ, Bryant HH, et al. Therapeutic implications of doxycycline and cephalothin concentrations in the female genital tract. Obstetrics and Gynecology 55: 28–32, 1980
Whelton A, Schach Von Wittenau M, Twomey TM, Walker WG, Bianchine JR. Doxycycline pharmacokinetics in the absence of renal function. Kidney International 5: 365–371, 1974
Wibell L, Fjellstrom KE. Doxycycline in daily routines. Opuscula Medica, Royal College of Physiology, London. S33: 72–79, 1974
Wojcicki J, Kalinowski W, Gawronska-Szlarz B. Comparative pharmacokinetics of doxycycline and oxytetracycline in patients with hyperlipidemia. Arzneimittel-Forschung 35: 991–993, 1985
Yim C, Flynn NN, Fitzgerald TF. Penetration of oral doxycycline into the cerebrospinal fluid of patients with latent or neurosyphilis. Antimicrobial Agents and Chemotherapy 28: 347–348, 1985
Ylitalo P, Hinkka H, Neuvonen PJ. Effect of exercise on the serum level and urinary excretion of tetracycline, doxycycline and sulphamethizole. European Journal of Clinical Pharmacology 12: 367–373, 1977
Zech PY. Remarques à propos de l’emploi de la doxycycline chez l’homme en insuffisance rénale. Nouvelle Presse Médicale 9: 82–83, 1980
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Saivin, S., Houin, G. Clinical Pharmacokinetics of Doxycycline and Minocycline. Clin-Pharmacokinet 15, 355–366 (1988). https://doi.org/10.2165/00003088-198815060-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-198815060-00001